Last updated on November 2019

Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines


Brief description of study

This is a multicenter, randomized, double-blind and placebo-controlled phase 2b dose-finding study to assess the efficacy and safety of LOU064 in adults chronic spontaneous urticaria (CSU) patients inadequately controlled by H1-antihistamines

Clinical Study Identifier: NCT03926611

Find a site near you

Start Over

Novartis Investigative Site

Itabashi-ku, Japan
4.8miles
  Connect »